Study of Binimetinib in Combination With Pembrolizumab in Advanced Non-Small Cell Lung Cancer

Condition:   Non-small Cell Carcinoma Interventions:   Drug: Binimetinib;   Drug: Pembrolizumab Sponsor:   University Health Network, Toronto Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials